Editorial: Progress and challenges in computational structure-based design and development of biologic drugs

Bibliographic Details
Main Authors: Traian Sulea, Sandeep Kumar, Daisuke Kuroda
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2024.1360267/full
_version_ 1797322336257441792
author Traian Sulea
Sandeep Kumar
Daisuke Kuroda
author_facet Traian Sulea
Sandeep Kumar
Daisuke Kuroda
author_sort Traian Sulea
collection DOAJ
first_indexed 2024-03-08T05:11:48Z
format Article
id doaj.art-15c7c763f0fa4e8ca32573338f362eba
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-03-08T05:11:48Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-15c7c763f0fa4e8ca32573338f362eba2024-02-07T05:33:59ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2024-02-011110.3389/fmolb.2024.13602671360267Editorial: Progress and challenges in computational structure-based design and development of biologic drugsTraian Sulea0Sandeep Kumar1Daisuke Kuroda2Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC, CanadaComputational Protein Design and Modeling, Computational Science, Moderna Therapeutics, Cambridge, MA, United StatesResearch Center of Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japanhttps://www.frontiersin.org/articles/10.3389/fmolb.2024.1360267/fullbinding affinityspecificitytherapeutic antibodydevelopabilityin silico methodmolecular modeling
spellingShingle Traian Sulea
Sandeep Kumar
Daisuke Kuroda
Editorial: Progress and challenges in computational structure-based design and development of biologic drugs
Frontiers in Molecular Biosciences
binding affinity
specificity
therapeutic antibody
developability
in silico method
molecular modeling
title Editorial: Progress and challenges in computational structure-based design and development of biologic drugs
title_full Editorial: Progress and challenges in computational structure-based design and development of biologic drugs
title_fullStr Editorial: Progress and challenges in computational structure-based design and development of biologic drugs
title_full_unstemmed Editorial: Progress and challenges in computational structure-based design and development of biologic drugs
title_short Editorial: Progress and challenges in computational structure-based design and development of biologic drugs
title_sort editorial progress and challenges in computational structure based design and development of biologic drugs
topic binding affinity
specificity
therapeutic antibody
developability
in silico method
molecular modeling
url https://www.frontiersin.org/articles/10.3389/fmolb.2024.1360267/full
work_keys_str_mv AT traiansulea editorialprogressandchallengesincomputationalstructurebaseddesignanddevelopmentofbiologicdrugs
AT sandeepkumar editorialprogressandchallengesincomputationalstructurebaseddesignanddevelopmentofbiologicdrugs
AT daisukekuroda editorialprogressandchallengesincomputationalstructurebaseddesignanddevelopmentofbiologicdrugs